Scott N. Greenberg - 14 Jun 2023 Form 4 Insider Report for VerifyMe, Inc. (VRME)

Signature
/s/ Margaret Gezerlis, Attorney-in-Fact for Scott Greenberg
Issuer symbol
VRME
Transactions as of
14 Jun 2023
Net transactions value
+$710
Form type
4
Filing time
16 Jun 2023, 16:32:29 UTC
Previous filing
13 Jun 2023
Next filing
29 Aug 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRME Common Stock, par value $0.001 Purchase $710 +500 +0.24% $1.42 212,572 14 Jun 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VRME Restricted Stock Units 56,819 14 Jun 2023 Common Stock, par value $0.001 56,819 $0.000000 Direct F3, F4
holding VRME Restricted Stock Units 30,000 14 Jun 2023 Common Stock, par value $0.001 30,000 $0.000000 Direct F5, F6
holding VRME Stock Option (Right to Buy) 10,000 14 Jun 2023 Common Stock, par value $0.001 10,000 $3.50 Direct F7
holding VRME Warrant (Right to Buy) 15,552 14 Jun 2023 Common Stock, par value $0.001 15,552 $3.22 Direct
holding VRME Warrant (Right to Buy) 6,403 14 Jun 2023 Common Stock, par value $0.001 6,403 $4.60 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 68,310 vested restricted stock units that become payable, on a one-for-one basis, in shares of common stock of VerifyMe, Inc. upon separation of the Reporting Person's service as a director.
F2 Includes 86,806 shares of restricted stock that vest on June 7, 2024, except as otherwise provided in the award notice.
F3 These restricted stock units, which convert into common stock on a one-for-one basis, vest on 3/15/2025 in two equal tranches, except as otherwise provided in the award notice. Tranch 1 will vest on the second anniversary of the date of grant if the issuer's common stock during such period was at or above $2.75 for 20 consecutive trading days. In the event that the issuer's common stock during such period does not reach $2.75 for 20 consecutive trading days, Tranch 1 will vest on the third anniversary of the date of grant if the issuer's common stock during such period was at or above $2.75 for 20 consecutive trading days.
F4 (Continued from footnote 3) Tranch 2 will vest on the second anniversary of the date of grant if the issuer's common stock during such period was at or above $3.75 for 20 consecutive trading days. In the event that the issuer's common stock during such period does not reach $3.75 for 20 consecutive trading days, Tranch 2 will vest on the third anniversary of the date of grant if the issuer's common stock during such period was at or above $3.75 for 20 consecutive trading days.
F5 These restricted stock units, which convert into common stock on a one-for-one basis, vest on 4/7/2024 in two equal tranches, except as otherwise provided in the award notice. Tranch 1 will vest on the second anniversary of the date of grant if the issuer's common stock during such period was at or above $5.00 for 20 consecutive trading days. In the event that the issuer's common stock during such period does not reach $5.00 for 20 consecutive trading days, Tranch 1 will vest on the third anniversary of the date of grant if the issuer's common stock during such period was at or above $5.00 for 20 consecutive trading days.
F6 (Continued from footnote 5) Tranch 2 will vest on the second anniversary of the date of grant if the issuer's common stock during such period was at or above $7.00 for 20 consecutive trading days. In the event that the issuer's common stock during such period does not reach $7.00 for 20 consecutive trading days, Tranch 2 will vest on the third anniversary of the date of grant if the issuer's common stock during such period was at or above $7.00 for 20 consecutive trading days.
F7 This option is fully exercisable as of the date of this report.